US 8431124
Methods for treating a disease characterized by an excess of hyaluronan by administering a soluble hyaluronidase glycoprotein (sHASEGP)
granted A61KA61K2039/505A61K38/00
Quick answer
US patent 8431124 (Methods for treating a disease characterized by an excess of hyaluronan by administering a soluble hyaluronidase glycoprotein (sHASEGP)) held by HALOZYME, INC. expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- HALOZYME, INC.
- Grant date
- Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K2039/505, A61K38/00, A61K38/47, A61K39/395